pirenzepine has been researched along with Intracranial Arteriosclerosis in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, A | 1 |
| Koyama, M | 1 |
| Miyazaki, K | 1 |
| Tagawa, S | 1 |
| Takase, K | 1 |
| Nakano, T | 1 |
| Tameda, Y | 1 |
| Kosaka, Y | 1 |
1 review available for pirenzepine and Intracranial Arteriosclerosis
| Article | Year |
|---|---|
[A case report of drug induced hepatitis and pancreatitis].
Topics: Aged; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Female; Fibrinolytic Agents; Hu | 1997 |